Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig L Slingluff

Showing results (101-110 of 225) with videos related to

Pageof 23
Sort By:
Journal of Translational Medicine|August 24, 2010
Dynamic changes in cellular infiltrates with repeated cutaneous vaccination: a histologic and immunophenotypic analysisJochen T Schaefer, James W Patterson, Donna H Deacon, et al.
Cancer Immunology, Immunotherapy : CII|September 21, 2004
Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family membersKevin T Hogan, Jennifer N Sutton, Kyo U Chu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2009
Patients with Merkel cell carcinoma tumors < or = 1.0 cm in diameter are unlikely to harbor regional lymph node metastasisJayme B Stokes, Katherine S Graw, Lynn T Dengel, et al.
Journal for Immunotherapy of Cancer|June 9, 2021
Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanomaKevin T Lynch, Samuel J Young, Max O Meneveau, et al.
Journal of Translational Medicine|August 31, 2017
Vaccine-draining lymph nodes of cancer patients for generating anti-cancer antibodiesGirja S Shukla, Walter C Olson, Stephanie C Pero, et al.
Surgery|May 18, 2019
Bariatric surgery is independently associated with a decrease in the development of colorectal lesionsMinyoung Kwak, J Hunter Mehaffey, Robert B Hawkins, et al.
Cancer Medicine|April 16, 2026
Immunotherapy Administration and Survival for Stage IV Melanoma Patients at Minority-Serving HospitalsMackenzie M Mayhew, Zoe Hemmer, Elizabeth J Olecki, et al.
Oncoimmunology|December 22, 2016
PD-L1, PD-L2 and PD-1 expression in metastatic melanoma: Correlation with tumor-infiltrating immune cells and clinical outcomeJoseph M Obeid, Gulsun Erdag, Mark E Smolkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanomaGeoffrey R Weiss, William W Grosh, Kimberly A Chianese-Bullock, et al.
Cancer Immunology, Immunotherapy : CII|April 24, 2014
Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccineYinin Hu, Gina R Petroni, Walter C Olson, et al.
Pageof 23

Showing results (101-110 of 225) with videos related to

Sort By:
Pageof 23
Journal of Translational Medicine|August 24, 2010
Dynamic changes in cellular infiltrates with repeated cutaneous vaccination: a histologic and immunophenotypic analysisJochen T Schaefer, James W Patterson, Donna H Deacon, et al.
Cancer Immunology, Immunotherapy : CII|September 21, 2004
Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family membersKevin T Hogan, Jennifer N Sutton, Kyo U Chu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2009
Patients with Merkel cell carcinoma tumors < or = 1.0 cm in diameter are unlikely to harbor regional lymph node metastasisJayme B Stokes, Katherine S Graw, Lynn T Dengel, et al.
Journal for Immunotherapy of Cancer|June 9, 2021
Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanomaKevin T Lynch, Samuel J Young, Max O Meneveau, et al.
Journal of Translational Medicine|August 31, 2017
Vaccine-draining lymph nodes of cancer patients for generating anti-cancer antibodiesGirja S Shukla, Walter C Olson, Stephanie C Pero, et al.
Surgery|May 18, 2019
Bariatric surgery is independently associated with a decrease in the development of colorectal lesionsMinyoung Kwak, J Hunter Mehaffey, Robert B Hawkins, et al.
Cancer Medicine|April 16, 2026
Immunotherapy Administration and Survival for Stage IV Melanoma Patients at Minority-Serving HospitalsMackenzie M Mayhew, Zoe Hemmer, Elizabeth J Olecki, et al.
Oncoimmunology|December 22, 2016
PD-L1, PD-L2 and PD-1 expression in metastatic melanoma: Correlation with tumor-infiltrating immune cells and clinical outcomeJoseph M Obeid, Gulsun Erdag, Mark E Smolkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanomaGeoffrey R Weiss, William W Grosh, Kimberly A Chianese-Bullock, et al.
Cancer Immunology, Immunotherapy : CII|April 24, 2014
Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccineYinin Hu, Gina R Petroni, Walter C Olson, et al.
Pageof 23